Item
News Article: Pfizer Injects AI Into Vaccine Trials
Title (Dublin Core)
News Article: Pfizer Injects AI Into Vaccine Trials
Description (Dublin Core)
This sub-article was the lead item in this week's Wall Street Journal PRO "Artificial Intelligence Weekly" email blast:
"By Angus Loten
Welcome back. Artificial intelligence is set to take a decisive role in shaping the post-pandemic economy, from helping employers reopen workplaces to getting supply chains back on track. Corporate technology leaders and industry analysts offered these and other insights at last week’s virtual edition of the WSJ Pro AI Executive Forum. Some of their views are outlined in the sections below. One broad takeaway: Though still in its infancy, AI is already having a profound impact on our daily lives.
Pfizer’s Speedy Vaccine Rollout
Pfizer Inc. last year developed AI-powered dashboards designed to monitor the effect of Covid-19 on clinical trials in real time, ultimately helping the pharmaceutical giant roll out its coronavirus vaccination in less than a year, The Wall Street Journal’s Sara Castellanos reports.
A shot in the arm. Pfizer fed large amounts of case-rate data into AI-enabled predictive models to quickly generate site selection for clinical trials, said Lidia Fonseca, the company’s chief digital and technology officer.
A smart move. Pfizer two years ago began experimenting with the emerging technologies, focusing on digital tools that promised to offer better outcomes for patients, doctors and employees, with results it was able to draw on during the pandemic, Ms. Fonseca said."
"By Angus Loten
Welcome back. Artificial intelligence is set to take a decisive role in shaping the post-pandemic economy, from helping employers reopen workplaces to getting supply chains back on track. Corporate technology leaders and industry analysts offered these and other insights at last week’s virtual edition of the WSJ Pro AI Executive Forum. Some of their views are outlined in the sections below. One broad takeaway: Though still in its infancy, AI is already having a profound impact on our daily lives.
Pfizer’s Speedy Vaccine Rollout
Pfizer Inc. last year developed AI-powered dashboards designed to monitor the effect of Covid-19 on clinical trials in real time, ultimately helping the pharmaceutical giant roll out its coronavirus vaccination in less than a year, The Wall Street Journal’s Sara Castellanos reports.
A shot in the arm. Pfizer fed large amounts of case-rate data into AI-enabled predictive models to quickly generate site selection for clinical trials, said Lidia Fonseca, the company’s chief digital and technology officer.
A smart move. Pfizer two years ago began experimenting with the emerging technologies, focusing on digital tools that promised to offer better outcomes for patients, doctors and employees, with results it was able to draw on during the pandemic, Ms. Fonseca said."
Date (Dublin Core)
April 6, 2021
Creator (Dublin Core)
Angus Loten
Contributor (Dublin Core)
James Rayroux
Event Identifier (Dublin Core)
HST580
Partner (Dublin Core)
Arizona State University
Type (Dublin Core)
online news article
Link (Bibliographic Ontology)
https://artificialintelligence.cmail19.com/t/ViewEmail/d/4B0D79FB5DBF00532540EF23F30FEDED/E54D9E4041F91C29C35B3650D253B2D9
Controlled Vocabulary (Dublin Core)
English
Economy
English
Technology
English
Healthcare
Curator's Tags (Omeka Classic)
Pfizer
vaccine
artificial intelligence
economy
digital tool
pharmaceutical
Contributor's Tags (a true folksonomy) (Friend of a Friend)
artificial intelligence
AI
computer learning
WSJ
Wall Street Journal
Pfizer
data
vaccine
vaccination
Collection (Dublin Core)
Vaccine Stories
Healthcare
Linked Data (Dublin Core)
Date Submitted (Dublin Core)
04/06/2021
Date Modified (Dublin Core)
04/10/2021
08/02/2022
09/09/2024
Item sets
This item was submitted on April 6, 2021 by James Rayroux using the form “Share Your Story” on the site “A Journal of the Plague Year”: http://covid-19archive.org/s/archive
Click here to view the collected data.